Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
Hepatocellular carcinoma (HCC) is one of the most common primary cancers with limited therapeutic options. Melatonin, a neuroendocrine hormone produced primarily by the pineal gland, demonstrates an anti-cancer effect on a myriad of cancers including HCC. However, whether melatonin could suppress tu...
Main Authors: | Lu Bai, Siwen Sun, Wenmei Su, Chaoqun Chen, Yuesheng Lv, Jinrui Zhang, Jinyao Zhao, Man Li, Yangfan Qi, Wenjing Zhang, Yang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1007006/full |
Similar Items
-
A comprehensive cost performance analysis for a QoS-based scheme in network mobility (NEMO)
by: Loay F. Hussein, et al.
Published: (2023-08-01) -
NEMO Gene Mutations in Two Chinese Females with Incontinentia Pigmenti
by: Jiang J, et al.
Published: (2022-05-01) -
Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO
by: Naga Suresh Adapala, et al.
Published: (2020-03-01) -
Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
by: Miltiadis Tsesmelis, et al.
Published: (2021-09-01) -
“KAYIP BALIK NEMO”DA MASAL İŞLEVLERİ
by: Tamer KAVURAN
Published: (2015-01-01)